Cargando…
Transactivation of epidermal growth factor receptor through platelet-activating factor/receptor in ovarian cancer cells
BACKGROUND: We previously identified platelet-activating factor receptor (PAFR) as being overexpressed in ovarian cancer and found that its ligand PAF evoked EGFR phosphorylation using the phospho-antibody microarray. Epidermal growth factor receptor (EGFR) are also overexpressed in ovarian cancer a...
Autores principales: | Yu, Yi, Zhang, Mingxing, Zhang, Xiaoyan, Cai, Qingqing, Zhu, Zhiling, Jiang, Wei, Xu, Congjian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189590/ https://www.ncbi.nlm.nih.gov/pubmed/25261977 http://dx.doi.org/10.1186/s13046-014-0085-6 |
Ejemplares similares
-
Epidermal growth factor induces platelet-activating factor production through receptors transactivation and cytosolic phospholipase A(2) in ovarian cancer cells
por: Yu, Yi, et al.
Publicado: (2014) -
Synergistic effects of combined platelet-activating factor receptor and epidermal growth factor receptor targeting in ovarian cancer cells
por: Yu, Yi, et al.
Publicado: (2014) -
Dexmedetomidine-Induced Aortic Contraction Involves Transactivation of the Epidermal Growth Factor Receptor in Rats
por: Lee, Soo Hee, et al.
Publicado: (2022) -
Transactivation of Epidermal Growth Factor Receptor by G Protein-Coupled Receptors: Recent Progress, Challenges and Future Research
por: Wang, Zhixiang
Publicado: (2016) -
Orthovanadate-induced vasocontraction is mediated by the activation of Rho-kinase through Src-dependent transactivation of epidermal growth factor receptor
por: Yayama, Katsutoshi, et al.
Publicado: (2014)